Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index (S&P TMI). more
| Time Frame | XPH | S&P500 |
|---|---|---|
| 1-Week Return | -4.83% | 1.24% |
| 1-Month Return | -9.55% | 1.17% |
| 3-Month Return | -5.38% | 3.14% |
| 6-Month Return | 17.13% | 17.61% |
| 1-Year Return | 30.91% | 15.37% |
| 3-Year Return | 64.24% | 82.69% |
| 5-Year Return | 35.88% | 78.96% |
| 10-Year Return | 41.09% | 259.83% |
| Time Frame | XPH | S&P500 |
|---|---|---|
| 1-Week Return | -92.43% | 90.14% |
| 1-Month Return | -70.51% | 15.20% |
| 3-Month Return | -20.09% | 13.36% |
| 6-Month Return | 37.80% | 38.95% |
| 1-Year Return | 30.91% | 15.37% |
| 3-Year Return | 17.98% | 22.25% |
| 5-Year Return | 6.32% | 12.34% |
| 10-Year Return | 3.50% | 13.66% |
| Stock name | Ticker | Weight |
|---|---|---|
XERIS BIOPHARMA HOLDINGS INC
|
XERS |
2.43%
|
VERADERMICS INC
|
MANE |
2.39%
|
AMNEAL PHARMACEUTICALS INC
|
AMRX |
2.36%
|
VIATRIS INC
|
VTRS |
2.15%
|
LIGAND PHARMACEUTICALS
|
LGND |
2.13%
|
ANI PHARMACEUTICALS INC
|
ANIP |
2.09%
|
ELI LILLY + CO
|
LLY |
2.07%
|
INDIVIOR PHARMACEUTICALS INC
|
INDV |
2.06%
|
PFIZER INC
|
PFE |
2.05%
|
ORGANON + CO
|
OGN |
2.03%
|
SUPERNUS PHARMACEUTICALS INC
|
SUPN |
2.03%
|
DEFINIUM THERAPEUTICS INC
|
DFTX |
2.01%
|
CORCEPT THERAPEUTICS INC
|
CORT |
2%
|
PERRIGO CO PLC
|
PRGO |
1.98%
|
MERCK + CO. INC.
|
MRK |
1.98%
|
INNOVIVA INC
|
INVA |
1.97%
|
JOHNSON + JOHNSON
|
JNJ |
1.96%
|
JAZZ PHARMACEUTICALS PLC
|
JAZZ |
1.96%
|
MAZE THERAPEUTICS INC
|
MAZE |
1.96%
|
OMEROS CORP
|
OMER |
1.93%
|
ROYALTY PHARMA PLC CL A
|
RPRX |
1.93%
|
HARMONY BIOSCIENCES HOLDINGS
|
HRMY |
1.93%
|
BRISTOL MYERS SQUIBB CO
|
BMY |
1.92%
|
ZOETIS INC
|
ZTS |
1.91%
|
SEPTERNA INC
|
SEPN |
1.9%
|
EDGEWISE THERAPEUTICS INC
|
EWTX |
1.89%
|
ELANCO ANIMAL HEALTH INC
|
ELAN |
1.87%
|
PRESTIGE CONSUMER HEALTHCARE
|
PBH |
1.86%
|
COLLEGIUM PHARMACEUTICAL INC
|
COLL |
1.85%
|
TARSUS PHARMACEUTICALS INC
|
TARS |
1.85%
|
MBX BIOSCIENCES INC
|
MBX |
1.82%
|
ETON PHARMACEUTICALS INC
|
ETON |
1.79%
|
PACIRA BIOSCIENCES INC
|
PCRX |
1.77%
|
AMYLYX PHARMACEUTICALS INC
|
AMLX |
1.76%
|
AXSOME THERAPEUTICS INC
|
AXSM |
1.75%
|
NUVATION BIO INC
|
NUVB |
1.73%
|
TREVI THERAPEUTICS INC
|
TRVI |
1.73%
|
HARROW INC
|
HROW |
1.65%
|
ENLIVEN THERAPEUTICS INC
|
ELVN |
1.63%
|
AMPHASTAR PHARMACEUTICALS IN
|
AMPH |
1.55%
|
ALUMIS INC
|
ALMS |
1.49%
|
WAVE LIFE SCIENCES INC
|
WVE |
1.46%
|
ZEVRA THERAPEUTICS INC
|
ZVRA |
1.46%
|
RAPPORT THERAPEUTICS INC
|
RAPP |
1.41%
|
LB PHARMACEUTICALS INC
|
LBRX |
1.37%
|
OCULAR THERAPEUTIX INC
|
OCUL |
1.29%
|
ALTO NEUROSCIENCE INC
|
ANRO |
1.25%
|
CORMEDIX INC
|
CRMD |
1.23%
|
PHIBRO ANIMAL HEALTH CORP A
|
PAHC |
1.2%
|
AQUESTIVE THERAPEUTICS INC
|
AQST |
1.14%
|
PHATHOM PHARMACEUTICALS INC
|
PHAT |
1.13%
|
ACLARIS THERAPEUTICS INC
|
ACRS |
0.98%
|
RELMADA THERAPEUTICS INC
|
RLMD |
0.94%
|
AVALYN PHARMA INC
|
AVLN |
0.84%
|
LIQUIDIA CORP
|
LQDA |
0.82%
|
LEXICON PHARMACEUTICALS INC
|
LXRX |
0.81%
|
ARVINAS INC
|
ARVN |
0.74%
|
EYEPOINT INC
|
EYPT |
0.71%
|
EVOLUS INC
|
EOLS |
0.71%
|
BIOAGE LABS INC
|
BIOA |
0.68%
|
CONTINEUM THERAPEUTICS INC A
|
CTNM |
0.64%
|
SSI US GOV MONEY MARKET CLASS
|
SSI.US.GOV.MONEY.MARKET.CLASS |
0.05%
|
CONTRA ESPERION THERAP
|
CONTRA.ESPERION.THERAP |
0.01%
|
US DOLLAR
|
US.DOLLAR |
0%
|
| Sector | Weight |
|---|---|
|
Health care
|
100.00% |
SPDR® S&P Pharmaceuticals ETF (XPH) share price today is $62.8.
Yes, Indians can buy shares of SPDR® S&P Pharmaceuticals ETF (XPH) on Vested. To buy XPH from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of SPDR® S&P Pharmaceuticals ETF (XPH) on Vested. You can start investing in SPDR® S&P Pharmaceuticals ETF (XPH) with a minimum investment of $1.
The 52-week high price of SPDR® S&P Pharmaceuticals ETF (XPH) is $74.3. The 52-week low price of SPDR® S&P Pharmaceuticals ETF (XPH) is $46.68.
The stock symbol (or ticker) of SPDR® S&P Pharmaceuticals ETF is XPH.
Yes, you can setup SIP in SPDR® S&P Pharmaceuticals ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of XPH on the Vested app.
The expense ratio of SPDR® S&P Pharmaceuticals ETF (XPH) is 0.35%.
Link copied